GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

80 hedge funds and large institutions have $38.6M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

53% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 30

Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$982K
Puts
$200K
Net Calls
Net Calls Change

Top Buyers

1
+$662K
2
+$522K
3
+$465K
4
Renaissance Technologies
Renaissance Technologies
New York
+$321K
5
BCM
Bridgeway Capital Management
Texas
+$286K

Top Sellers

1
-$2.36M
2
-$1.76M
3
-$769K
4
Bank of America
Bank of America
North Carolina
-$705K
5
Millennium Management
Millennium Management
New York
-$665K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
$498
77
$353
78
$125
79
$125
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
94
–
95
–
96
–
97
–
98
–
99
–
100
–
1 2 3
4
5